When the bacteria in your large intestine break down fiber, they release a small group of fatty acids that feed your gut lining and influence inflammation, blood sugar, and even brain signaling. Acetate is the largest share of this output. The percentage on this report tells you how much of your gut's fermentation work is going into acetate versus the other two main fatty acids, butyrate and propionate.
This is a research-stage marker. There is no agreed-upon ideal number, and the studies that exist are mostly in narrow populations like preterm infants. What this test gives you is a window into the proportional balance of your microbial fermentation, useful as a baseline you can track if you are working on your gut over time.
Acetate is one of the short-chain fatty acids (SCFAs), the small molecules your gut bacteria make when they ferment dietary fiber and resistant starch. Your colon cells absorb most of it, and what is left over passes into your stool. The lab measures the three main saccharolytic SCFAs (acetate, butyrate, and propionate) and reports each one as a percentage of the total.
Acetate is normally the dominant share. Across studied populations, it tends to make up the large majority of saccharolytic SCFAs, with butyrate and propionate filling in the rest. The percentage shifts with the makeup of your microbial community, your fiber intake, and how the sample is collected and processed.
Looking at acetate as a percentage rather than an absolute amount is a way to see the balance between the three main SCFAs without being thrown off by sample dilution or how much stool was collected. If acetate's share rises, the share of butyrate or propionate has to fall, and the reverse is also true. That tradeoff is why some clinicians look at the full SCFA profile together rather than any one fatty acid alone.
The science here is still developing. Most of the practical knowledge about which exact percentage corresponds to which health state has not been settled in human studies.
Direct human research linking the acetate percentage in stool to specific diseases is limited. The strongest finding comes from a small study in preterm infants. In that group, infants who developed early-onset sepsis around three days of life had a lower acetate share of total stool SCFAs (about 87%) compared with infants who did not develop sepsis (about 95%). The non-acetate fatty acids made up a larger share in the sepsis group, and the difference faded by one month of age.
A separate study in adults with mild cognitive impairment found lower fecal acetic acid levels (a related but different measurement, reported as a concentration rather than a percentage) compared with healthy controls. This is suggestive, not definitive, evidence that fermentation patterns shift in early neurodegenerative changes. Both findings come from observational studies in narrow populations and should not be applied directly to a healthy adult tracking their own gut.
There is no clinically validated optimal range for acetate as a percentage of saccharolytic SCFAs in adults. The numbers below come from a single study of preterm infants and are included only as research-reported orientation, not as a target for adults. Different labs use different methods, and your own report will likely include the lab's analytical reference range.
| Group | Reported Acetate Share | Source |
|---|---|---|
| Preterm infants without early-onset sepsis (around day 3 of life) | About 95% of total SCFAs | Kukaev et al., 2025 |
| Preterm infants with early-onset sepsis (around day 3 of life) | About 87% of total SCFAs | Kukaev et al., 2025 |
Compare your results within the same lab over time for the most useful trend. A single number means much less than a trajectory.
One stool reading captures a single snapshot of a microbial community that shifts daily with what you eat, how you sleep, and what bugs are dominant that week. For a research-stage marker like this, a trend tells you far more than a single value. Establish a baseline, then retest after 3 to 6 months if you are making meaningful changes to your diet or microbiome (significant fiber increases, new probiotics, antibiotic recovery), and at least annually after that if you are stable.
Watch the direction of the change rather than the exact number. A shift toward a more even split among acetate, butyrate, and propionate is generally what gut-health interventions aim for, though the precise targets remain an open research question.
Because this is a research-stage marker, do not act on the acetate percentage alone. The number is most useful in the context of the rest of your stool panel: butyrate percentage, propionate percentage, total SCFA output, calprotectin (a marker of gut inflammation), pancreatic elastase (a marker of digestive enzyme output), and the microbial community report.
Stool SCFA testing is sensitive to how the sample is collected, transported, and stored. Preanalytical conditions (collection equipment, temperature, transit time, freeze-thaw cycles, time from passage to processing) can shift the values you see on the report without anything having changed in your gut. Apparent variability between two readings can reflect handling differences rather than real biology.
Acetate is best interpreted alongside these tests.